Citation Impact
Citing Papers
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
2003 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Parenteral Anticoagulants
2012 Standout
Heparin-Protein Interactions
2002 Standout
Impact of protein-protein contacts on the conformation of thrombin-bound hirudin studied by comparison with the nuclear magnetic resonance solution structure of hirudin(1–51)
1992 StandoutNobel
Murine Heparin Cofactor II: Purification, cDNA Sequence, Expression, and Gene Structure
1994
Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review
2017 Standout
Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed
1990
Heparin Cofactor II
1997
Thrombin-induced platelet activation via PAR4: pivotal role for exosite II
2014 StandoutNobel
The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
1999 Standout
NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata
1994 StandoutNobel
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Recommendations for quantification of Doppler echocardiography: A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography
2002 Standout
Binding of Fibrin Monomer and Heparin to Thrombin in a Ternary Complex Alters the Environment of the Thrombin Catalytic Site, Reduces Affinity for Hirudin, and Inhibits Cleavage of Fibrinogen
1996
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study
2002
A DNA Aptamer That Binds Adenosine and ATP
1995 StandoutNobel
Clinical classification of pulmonary hypertension
2004 Standout
Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight
1992 Standout
The isomorphous structures of prethrombin2, hirugen–, and PPACK–thrombin: Changes accompanying activation and exosite binding to thrombin
1994
Fucoidan inhibits cellular and neurotoxic effects of β‐amyloid (Aβ) in rat cholinergic basal forebrain neurons
2005
Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension
1991 Standout
The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationships
1992
Selection of a Suppressor Mutation That Restores Affinity of an Oligonucleotide Inhibitor for Thrombin Using in Vitro Genetics
1995
Effects of inhibition of P2Y1 and P2Y12 on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry
2003 StandoutNobel
Anticoagulant and antithrombin activities of oversulfated fucans
1992
Production of chemotactic peptides by neutrophil degradation of heparin cofactor II
1990
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Pharmacodynamics, Clinical Indications, and Adverse Effects of Heparin
1992
Structure–function relationships of immunostimulatory polysaccharides: A review
2015 Standout
Nuclear magnetic resonance solution structure of hirudin(1–51) and comparison with corresponding three-dimensional structures determined using the complete 65-residue hirudin polypeptide chain
1992 StandoutNobel
A DNA metalloenzyme with DNA ligase activity
1995 StandoutNatureNobel
Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits
2001 Standout
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2016 Standout
Polyphosphate binds with high affinity to exosite II of thrombin
2009
The clot thickens: clues provided by thrombin structure
1995
Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products
1995
Evaluation of comparative protein modeling by MODELLER
1995 Standout
Refined structure of the Hirudin-thrombin complex
1991 Nobel
Differential activation and inhibition of human platelet thrombin receptors by structurally distinct α-, β- and γ-thrombin
2004
THE STRUCTURE OF ALPHA-THROMBIN INHIBITED BY A 15-MER SINGLE-STRANDED DNA APTAMER
1993
Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
1991 Standout
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach
1995
Isolation and partial characterization of a noval amino sugar-containing fucan sulfate from commercial Fucus vesiculosus fucoidan
1994
Characterisation of species differences in the platelet ADP and thrombin response
2005 StandoutNobel
A practical guide to assessment of ventricular diastolic function using doppler echocardiography
1996
A precise and fast temperature mapping using water proton chemical shift
1995
Selection of single-stranded DNA molecules that bind and inhibit human thrombin
1992 StandoutNature
Blood plasma coagulation studied by surface plasmon resonance
2000 StandoutNobel
Evaluation of electrocardiographic criteria for right atrial enlargement by quantitative two-dimensional echocardiography
1994
Antioxidant activity of sulfated polysaccharide fractions extracted from Laminaria japonica
2007 Standout
Glycosaminoglycans and the regulation of blood coagulation
1993
A player of many parts: The spotlight falls on thrombin's structure
1993
Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation
2006 Standout
The single-stranded DNA aptamer-binding site of human thrombin.
1993
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
1990
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Functional Nucleic Acid Sensors
2009 Standout
Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy
1986
Chitin/chitosan: modifications and their unlimited application potential—an overview
2007 Standout
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
2009
Serpin Structure, Mechanism, and Function
2002 Standout
Left ventricular performance in patients with coexistent mitral stenosis and aortic insufficiency
1984
The Structure of a Complex of Recombinant Hirudin and Human α-Thrombin
1990 ScienceNobel
The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
1991
Thrombin Activates Factor XI on Activated Platelets in the Absence of Factor XII
1999
Predisposing factors for the diabetic hyperosmolar state.
1987
Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans
1994
Capillary haemangiomatosis of the lungs
1978
Medicinal and pharmaceutical uses of seaweed natural products: A review
2004 Standout
Three-dimensional models of four mouse mast cell chymases. Identification of proteoglycan binding regions and protease-specific antigenic epitopes.
1993
Thrombin-Induced Platelet Activation Is Inhibited by High- and Low-Molecular-Weight Heparin
1999
Leukocyte chemoattractant peptides from the serpin heparin cofactor II.
1991
Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae
2010 Standout
Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin.
1995 Nobel
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Hyperglycemic Crises in Adult Patients With Diabetes
2009 Standout
Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin
2001
Heparin binding to protein C inhibitor.
1992
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Pathophysiology of Sleep Apnea
2010 Standout
Potential Antioxidant Capacity of Sulfated Polysaccharides from the Edible Marine Brown Seaweed Fucus vesiculosus
2002 Standout
The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer.
1993
A Cell-based Model of Hemostasis
2001 Standout
Role of lysine 173 in heparin binding to heparin cofactor II
1991
Reperfusion pulmonary edema after pulmonary artery thromboendarterectomy.
1986
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Fucoidan: Structure and Bioactivity
2008 Standout
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings.
1987
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
2009 Standout
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Glycosaminoglycan-mediated leuserpin-2/thrombin interaction. Structure-function relationships.
1990
Works of J. B. Meade being referenced
The results of surgery for atrial septal defect in patients
1990
Physicochemical Aspects of Heparin Cofactor IIa
1989
The relationship between hypertrophy and dilatation in the postmortem heart
1988
Structure-function relationships in heparin cofactor II: Spectral analysis of aromatic residues and absence of a role for sulfhydryl groups in thrombin inhibition
1987
Structural and functional properties of human α-thrombin, phosphopyridoxylated α-thrombin, and γT-thrombin
1989
Primary haemangiopericytoma of lung
1974
Combined mitral and aortic valve disease
1970
Acquired pulmonary stenosis
1970
Hyperosmolar hyperglycaemic non-ketotic diabetic coma complicating open heart surgery.
1972
Sensitivity of electrocardiographic criteria for left ventricular hypertrophy according to type of cardiac disease
1985
Reevaluation of electrocardiographic criteria for left, right and combined cardiac ventricular hypertrophy
1984
Peripheral vasoconstriction after open-heart surgery
1974
Antithrombin Activity of Fucoidan
1989
Descriptive characteristics of the electrocardiogram from autopsied men free of cardiopulmonary disease—A basis for evaluating criteria for ventricular hypertrophy
1983